These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 3092256

  • 21. [Synthesis and pharmacologic study of several spirohydantoins: relation to conformation].
    Courtoison JC, Coudert P, Couquelet J, Tronche P, Jonadet M, Bastide P.
    Farmaco Sci; 1988 Feb; 43(2):153-60. PubMed ID: 3134252
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Inhibition of aldose reductases from rat and bovine lenses by flavonoids.
    Okuda J, Miwa I, Inagaki K, Horie T, Nakayama M.
    Biochem Pharmacol; 1982 Dec 01; 31(23):3807-22. PubMed ID: 6818971
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Inhibition of aldose reductases from rat and bovine lenses by hydantoin derivatives.
    Inagaki K, Miwa I, Yashiro T, Okuda J.
    Chem Pharm Bull (Tokyo); 1982 Sep 01; 30(9):3244-54. PubMed ID: 6816474
    [No Abstract] [Full Text] [Related]

  • 26. [Substrate specificity and inhibition by various compounds of aldose reductase II from rabbit lens].
    Tanimoto T, Fukuda H, Kawamura J.
    Yakugaku Zasshi; 1984 Jun 01; 104(6):631-4. PubMed ID: 6438300
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008].
    Tasaka H, Akagi Y, Yoshikawa T, Ikebe H, Takahashi Y, Chamoto K, Miyamoto Y, Terubayashi H.
    Nippon Ganka Gakkai Zasshi; 1987 Feb 01; 91(2):246-53. PubMed ID: 3111200
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [2,2',4,4'-tetrahydroxybenzophenone as a new aldose reductase inhibitor (author's transl)].
    Ono H, Hayano S.
    Nippon Ganka Gakkai Zasshi; 1982 Feb 01; 86(4):353-7. PubMed ID: 6810663
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Diabetic cataracts in animal models: prevention and reversibility with aldose reductase inhibitors.
    Kador PF, Akagi Y, Kinoshita JH.
    Diabet Med; 1985 May 01; 2(3):194-6. PubMed ID: 2952419
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.